This company has been acquired
Paratek Pharmaceuticals Gelecekteki Büyüme
Future kriter kontrolleri 4/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Paratek Pharmaceuticals.
Anahtar bilgiler
73.2%
Kazanç büyüme oranı
72.9%
EPS büyüme oranı
Pharmaceuticals kazanç büyümesi | 24.4% |
Gelir büyüme oranı | 13.8% |
Gelecekteki özkaynak getirisi | n/a |
Analist kapsamı | Low |
Son güncelleme | 07 Aug 2023 |
Gelecekteki son büyüme güncellemeleri
Recent updates
Improved Revenues Required Before Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK) Stock's 77% Jump Looks Justified
Apr 17Paratek Pharmaceuticals: Patience Is Wearing Thin
Aug 24Paratek Pharmaceuticals GAAP EPS of -$0.33 beats by $0.01, revenue of $29.6M beats by $0.42M
Aug 03Paratek Pharmaceuticals: A Deeply Undervalued Antibiotic Company
Jan 03The Play On Paratek Pharmaceuticals
Oct 18Peeking Back In On Paratek Pharmaceuticals
Aug 07Paratek Pharma launches Phase 2b Nuzyra study in nontuberculous mycobacterial
Jun 16Paratek shares rise after FDA approves NUZYRA oral only dosing regimen
Jun 01Paratek Offers Long-Term Value Potential In The Difficult Antibiotic Business
Apr 27Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK): Are Analysts Optimistic?
Mar 01Could The Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK) Ownership Structure Tell Us Something Useful?
Feb 01Paratek Pharmaceuticals secures $60M non-recourse loan for Hercules debt repayment
Jan 04Paratek Pharmaceuticals: 100%+ Upside As Nuzyra Sales Scale
Dec 01Paratek Pharmaceuticals, Inc. 2020 Q3 - Results - Earnings Call Presentation
Nov 06Kazanç ve Gelir Büyüme Tahminleri
Tarih | Gelir | Kazançlar | Serbest Nakit Akışı | Faaliyetlerden Nakit | Avg. Analist Sayısı |
---|---|---|---|---|---|
12/31/2025 | 221 | 2 | -9 | N/A | 2 |
12/31/2024 | 218 | -14 | 30 | N/A | 3 |
12/31/2023 | 163 | -46 | -10 | N/A | 2 |
6/30/2023 | 177 | -63 | -23 | -23 | N/A |
3/31/2023 | 167 | -66 | -36 | -36 | N/A |
12/31/2022 | 160 | -64 | -66 | -66 | N/A |
9/30/2022 | 117 | -89 | -66 | -66 | N/A |
6/30/2022 | 111 | -86 | -27 | -27 | N/A |
3/31/2022 | 139 | -59 | -46 | -46 | N/A |
12/31/2021 | 130 | -59 | -49 | -48 | N/A |
9/30/2021 | 114 | -52 | -53 | -52 | N/A |
6/30/2021 | 104 | -54 | -108 | -107 | N/A |
3/31/2021 | 55 | -87 | -95 | -95 | N/A |
12/31/2020 | 47 | -97 | -104 | -103 | N/A |
9/30/2020 | 40 | -99 | -116 | -115 | N/A |
6/30/2020 | 30 | -111 | -115 | -114 | N/A |
3/31/2020 | 23 | -121 | -129 | -129 | N/A |
12/31/2019 | 17 | -129 | -134 | -134 | N/A |
9/30/2019 | 25 | -124 | -118 | -117 | N/A |
6/30/2019 | 21 | -124 | -110 | -110 | N/A |
3/31/2019 | 19 | -120 | -98 | -98 | N/A |
12/31/2018 | 17 | -112 | -81 | -81 | N/A |
9/30/2018 | 5 | -111 | -85 | -85 | N/A |
6/30/2018 | 5 | -101 | -80 | -80 | N/A |
3/31/2018 | 13 | -89 | -73 | -73 | N/A |
12/31/2017 | 13 | -89 | -80 | -79 | N/A |
9/30/2017 | 8 | -94 | -82 | -80 | N/A |
6/30/2017 | 8 | -96 | -95 | -94 | N/A |
3/31/2017 | 0 | -108 | N/A | -101 | N/A |
12/31/2016 | 0 | -112 | N/A | -94 | N/A |
9/30/2016 | N/A | -106 | N/A | -86 | N/A |
6/30/2016 | N/A | -106 | N/A | -78 | N/A |
3/31/2016 | N/A | -91 | N/A | -70 | N/A |
12/31/2015 | N/A | -71 | N/A | -55 | N/A |
9/30/2015 | 4 | -61 | N/A | -49 | N/A |
6/30/2015 | 4 | -42 | N/A | -30 | N/A |
3/31/2015 | 4 | -29 | N/A | -18 | N/A |
12/31/2014 | 4 | -20 | N/A | -19 | N/A |
9/30/2014 | 0 | -12 | N/A | -9 | N/A |
6/30/2014 | 1 | -11 | N/A | -8 | N/A |
3/31/2014 | 0 | -11 | N/A | -8 | N/A |
12/31/2013 | 0 | -11 | N/A | -6 | N/A |
9/30/2013 | 1 | -37 | N/A | -9 | N/A |
6/30/2013 | 1 | -41 | N/A | -11 | N/A |
3/31/2013 | 3 | -45 | N/A | -10 | N/A |
12/31/2012 | 3 | -50 | N/A | -12 | N/A |
9/30/2012 | 4 | -28 | N/A | -12 | N/A |
Analist Gelecek Büyüme Tahminleri
Kazançlar ve Tasarruf Oranları: PRTK is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.2%).
Kazançlar ve Piyasa: PRTK is forecast to become profitable over the next 3 years, which is considered above average market growth.
Yüksek Büyüme Kazançları: PRTK is expected to become profitable in the next 3 years.
Gelir ve Pazar: PRTK's revenue (13.8% per year) is forecast to grow faster than the US market (7.7% per year).
Yüksek Büyüme Geliri: PRTK's revenue (13.8% per year) is forecast to grow slower than 20% per year.
Hisse Başına Kazanç Büyüme Tahminleri
Gelecekteki Özkaynak Getirisi
Gelecekteki ROE: Insufficient data to determine if PRTK's Return on Equity is forecast to be high in 3 years time